+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Dermatologicals in Lithuania

  • PDF Icon

    Report

  • 21 Pages
  • September 2025
  • Region: Lithuania
  • Euromonitor International
  • ID: 2651652
Lithuania’s dermatologicals market is set to continue to expand in current value terms in 2025, with growth concentrated in vaginal antifungals, topical allergy remedies/antihistamines and cold sore treatments. These products are easy for consumers to select independently at major pharmacy chains, such as Eurovaistine, Gintarine, Camelia and BENU, whether in-store or online.

The Dermatologicals in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Dermatologicals market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2025 DEVELOPMENTS
  • Market continues to grow, led by vaginal antifungals, topical allergy remedies/antihistamines and cold sore treatments
  • Bayer AG leads the market, anchored by its Bepanthen and Canesten brands
  • Pharmacies continue to dominate sales
PROSPECTS AND OPPORTUNITIES
  • Premium formats and routine skin care concerns will sustain value sales
  • Digital innovation will drive growth of e-pharmacies
  • Wellness and eco-conscious upgrades to drive quality-led growth
CATEGORY DATA
  • Table 1 Sales of Dermatologicals by Category: Value 2020-2025
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2020-2025
  • Table 3 NBO Company Shares of Dermatologicals: % Value 2021-2025
  • Table 4 LBN Brand Shares of Dermatologicals: % Value 2022-2025
  • Table 5 Forecast Sales of Dermatologicals by Category: Value 2025-2030
  • Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN LITHUANIA
EXECUTIVE SUMMARY
  • Consumer health in 2025: The big picture
  • Key trends in 2025
  • Competitive landscape
  • Channel developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
  • Table 8 Life Expectancy at Birth 2020-2025
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2020-2025
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
  • Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
  • Table 13 Penetration of Private Label by Category: % Value 2020-2025
  • Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources